Indication
ESWL
1 clinical trial
1 product
1 drug
Clinical trial
The Efficacy and Safety of Medical Expulsive Therapy After Extracorporeal Shock Wave Lithotripsy (ESWL) in Pediatric UrolithiasisStatus: Active (not recruiting), Estimated PCD: 2023-12-01
Product
TamsulosinDrug
Varlilumab